Accelerator alumnus company Motilent receives FDA 510k clearance and national hospital partnership for gut-imaging software
Motilent’s product GIQuant®, provides a clinically validated, objective disease activity score for small bowel Crohn’s disease based on intestinal motility and has recently received FDA 510k clearance in the USA – the rollout of this technology will be in partnership with Nuance AI solutions.